Abumohssin Abdulelah G, Alnabihi Ahmed N, Alqahtani Abdullah S
Medicine and Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Medicine and Surgery, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Jeddah, SAU.
Cureus. 2023 Mar 17;15(3):e36274. doi: 10.7759/cureus.36274. eCollection 2023 Mar.
Acute lymphoblastic leukemia (ALL) is a hematological cancer that can cause ocular tissue involvement. Asparaginase is a chemotherapy regimen that is commonly used in leukemia which could lead to similar ocular manifestations. We report a patient with a history of ALL for seven months on asparaginase therapy and persistent cerebral sinus venous thrombosis (CSVT) with acute venous infarction in the left frontal lobe presented with worsening vision. On examination, he had a visual acuity (VA) of (6/21) in the right eye and (6/60) in the left eye, with a mild left eye abduction limitation. Fundal examination showed bilateral prominent multilayered retinal hemorrhages and papilledema with absence of leukemic infiltration. His chemotherapy regimen was held and a one month follow up was scheduled. Follow up after one month of chemotherapy cessation showed resolution of both VA and fundal exam findings. It is crucial to differentiate between asparaginase toxicity and infiltration of the disease in ALL patients. As this would determine whether the treatment should be continued or suspended.
急性淋巴细胞白血病(ALL)是一种可导致眼部组织受累的血液系统癌症。天冬酰胺酶是白血病常用的化疗方案,可能导致类似的眼部表现。我们报告一名有7个月ALL病史且接受天冬酰胺酶治疗的患者,出现持续性脑静脉窦血栓形成(CSVT)及左侧额叶急性静脉梗死,视力恶化。检查发现,他右眼视力(VA)为6/21,左眼为6/60,左眼外展轻度受限。眼底检查显示双侧视网膜有明显的多层出血和视乳头水肿,无白血病浸润。暂停其化疗方案并安排1个月的随访。化疗停止1个月后的随访显示视力和眼底检查结果均恢复正常。在ALL患者中,区分天冬酰胺酶毒性和疾病浸润至关重要。因为这将决定治疗应继续还是暂停。